Evidence map›Paper›PMID 37250382›Full record

ArticleJACC. Advances2023

Sex-Based Differences in Severe Outcomes, Including Cardiovascular Hospitalization, in Adults With COVID-19 in Ontario, Canada.

Bahar Behrouzi, Atul Sivaswamy, Anna Chu, Laura E Ferreira-Legere, Husam Abdel-Qadir, Clare L Atzema, Cynthia Jackevicius, Moira K Kapral, Harindra C Wijeysundera, Michael E Farkouh and 17 more

Open access · diamondAbstract read
In one paragraph

Article in JACC. Advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 6 institutions in 2 countries.

Bahar BehrouziInstitute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada.
Atul SivaswamyICES, Toronto, Canada.
Anna ChuICES, Toronto, Canada.
Laura E Ferreira-LegereICES, Toronto, Canada.
Husam Abdel-QadirInstitute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada.
Clare L AtzemaInstitute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada.
Cynthia JackeviciusInstitute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada.
Moira K KapralInstitute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada.
Harindra C WijeysunderaInstitute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada.
Michael E FarkouhPeter Munk Cardiac Centre, University Health Network, Toronto, Canada.
Heather J RossTemerty Faculty of Medicine, University of Toronto, Toronto, Canada.
Andrew C T HaDepartment of Medicine, University of Toronto, Toronto, Canada.
Mina TadrousICES, Toronto, Canada.
Michael PatersonInstitute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada.
Andrea S GershonInstitute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada.
Vladimír DžavíkPeter Munk Cardiac Centre, University Health Network, Toronto, Canada.
Jiming FangICES, Toronto, Canada.
Padma KaulCanadian VIGOUR Centre, University of Alberta, Edmonton, Canada.
Sean van DiepenCanadian VIGOUR Centre, University of Alberta, Edmonton, Canada.
Shaun G GoodmanDepartment of Medicine, University of Toronto, Toronto, Canada.
Justin A EzekowitzCanadian VIGOUR Centre, University of Alberta, Edmonton, Canada.
Kevin R BaineyCanadian VIGOUR Centre, University of Alberta, Edmonton, Canada.
Dennis T KoInstitute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada.
Peter C AustinInstitute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada.
Finlay A McAlisterCanadian VIGOUR Centre, University of Alberta, Edmonton, Canada.
Douglas S LeeInstitute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada.
Jacob A UdellInstitute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada.
University of Toronto · CAUniversity Health Network · CAUniversity of Alberta · CAInstitute for Clinical Evaluative Sciences · CASunnybrook Health Science Centre · CASt. Michael's Hospital · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: While men have experienced higher risks of SARS-CoV-2 infection compared to women, an analysis of sex differences by age in severe outcomes during the acute phase of infection is lacking. Objectives: The purpose of this study was to assess heterogeneity in severe outcome risks by age and sex by conducting a retrospective cohort study of community-dwelling adults in Ontario who tested positive for SARS-CoV-2 infection during the first 3 waves. Methods: Adjusted odds ratios were estimated using multilevel multivariable logistic regression models including an interaction term for age and sex. The primary outcome was a composite of severe outcomes (hospitalization for a cardiovascular (CV) event, intensive care unit admission, mechanical ventilation, or death) within 30 days. Results: Among 30,736, 199,132, and 186,131 adults who tested positive during the first 3 waves, 1,908 (6.2%), 5,437 (2.7%), and 5,653 (3.0%) experienced a severe outcome within 30 days. For all outcomes, the sex-specific risk depended on age (all Conclusions: To mitigate risks in subsequent waves, it is helpful to further understand the factors that contribute to the generally higher risks faced by men across all ages, and the persistent or increasing sex disparity in the risk of CV hospitalization.

Indexed as

cardiovascular diseasehealth administrative dataPCRpopulation-basedSARS-CoV-2vaccination

Identifiers

PMID37250382
PMCPMC10171238
OpenAlexW4378745707

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.